SCUTERI, Damiana
 Distribuzione geografica
Continente #
NA - Nord America 2.754
AS - Asia 2.195
EU - Europa 1.172
SA - Sud America 539
Continente sconosciuto - Info sul continente non disponibili 153
AF - Africa 151
OC - Oceania 9
Totale 6.973
Nazione #
US - Stati Uniti d'America 2.591
SG - Singapore 946
IT - Italia 441
CN - Cina 405
VN - Vietnam 366
BR - Brasile 362
UA - Ucraina 157
DE - Germania 133
FR - Francia 88
AT - Austria 78
SN - Senegal 77
IN - India 76
CA - Canada 73
HK - Hong Kong 67
FI - Finlandia 61
AR - Argentina 58
BD - Bangladesh 57
GB - Regno Unito 51
SE - Svezia 48
KR - Corea 42
TR - Turchia 40
MX - Messico 37
EC - Ecuador 31
IQ - Iraq 27
JP - Giappone 24
CO - Colombia 23
PK - Pakistan 23
RU - Federazione Russa 22
VE - Venezuela 21
ZA - Sudafrica 21
ID - Indonesia 20
MA - Marocco 17
CL - Cile 15
CZ - Repubblica Ceca 13
NL - Olanda 13
UZ - Uzbekistan 13
PY - Paraguay 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
SA - Arabia Saudita 9
SV - El Salvador 9
AU - Australia 8
BE - Belgio 8
JM - Giamaica 8
JO - Giordania 8
NI - Nicaragua 8
AL - Albania 7
EG - Egitto 7
KE - Kenya 7
MY - Malesia 7
PH - Filippine 7
BO - Bolivia 6
CH - Svizzera 6
CW - ???statistics.table.value.countryCode.CW??? 6
ES - Italia 6
IE - Irlanda 6
KZ - Kazakistan 6
LT - Lituania 6
NP - Nepal 6
PE - Perù 6
UY - Uruguay 6
CR - Costa Rica 5
GP - Guadalupe 5
GR - Grecia 5
OM - Oman 5
PL - Polonia 5
HN - Honduras 4
IL - Israele 4
PS - Palestinian Territory 4
BH - Bahrain 3
BY - Bielorussia 3
DZ - Algeria 3
ET - Etiopia 3
MK - Macedonia 3
PR - Porto Rico 3
TH - Thailandia 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
AZ - Azerbaigian 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GH - Ghana 1
Totale 6.817
Città #
Singapore 397
Ashburn 298
Chandler 279
San Jose 224
Council Bluffs 219
Boardman 151
Ho Chi Minh City 134
Dallas 129
Beijing 104
New York 103
Jacksonville 88
San Mateo 82
Dakar 77
Hanoi 72
Hong Kong 63
Vienna 60
Helsinki 56
Milan 49
Lauterbourg 48
Hefei 43
Shanghai 43
São Paulo 40
Seoul 39
Lawrence 36
Roxbury 36
Los Angeles 35
Rende 34
Dearborn 31
Brooklyn 28
Ottawa 27
Rome 25
Cosenza 24
Guangzhou 24
Santa Clara 24
Des Moines 23
Tokyo 22
Cambridge 21
Da Nang 21
Ogden 20
Chicago 19
Falkenstein 18
Phoenix 17
Catanzaro 16
Biên Hòa 15
Orem 15
Catania 14
Florence 14
Mumbai 14
Toronto 14
Afyonkarahisar 13
Ann Arbor 13
Baghdad 13
Guayaquil 13
Wilmington 13
Atlanta 12
Izmir 12
Chennai 11
Haiphong 11
Montreal 11
Naples 11
Pune 11
Hải Dương 10
Miano 10
Rio de Janeiro 10
Tashkent 10
West Jordan 10
Brno 9
Coudersport 9
Nuremberg 9
Quito 9
Redwood City 9
Belo Horizonte 8
Columbus 8
Inglewood 8
Lamezia Terme 8
Managua 8
Porto Alegre 8
San Salvador 8
Seattle 8
Thái Bình 8
Tianjin 8
Washington 8
Amman 7
Cape Town 7
Caracas 7
Frankfurt am Main 7
London 7
Manchester 7
Mexico City 7
Munich 7
Nairobi 7
Wuhan 7
Basingstoke 6
Bogotá 6
Boston 6
Brussels 6
Casablanca 6
Denver 6
Goiânia 6
Guardavalle 6
Totale 3.830
Nome #
Nanotechnology-based deliviery system of bergamot essential oil, method of preparation of the system and uses thereof. 267
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 225
Bergamot essential oil attenuates anxiety-like behaviour in rats 217
Aging brain: In search for better neurotherapeutics 204
Book of Abstracts – Aging Brain: In Search for Better Neurotherapeutics. 193
Ageing affects nociception in C57BL/6 mice. 189
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Clinical Evidence and Possible Mechanisms 174
Book of Abstracts – Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation. 173
Book of Abstracts - NEW TRENDS IN PAIN RESEARCH From Basic Research to Clinical Translation 168
Pharmacological basis for the treatment of Behavioural and Psychological Symptoms of Dementia (BPSDs) With Aromatherapy 146
Opioids Resistance in Chronic Pain Management 144
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 141
Benefits and risks associated with cannabis and cannabis derivatives use 136
Anxiolytic-like/relaxant effects of BEO are useful to manage anxiety and agitation symptoms observed in patients with dementia 129
Spinal expression of autophagic markers following intraplantar formalin injection 129
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 128
Aging Brain: In Search of Better Neurotherapeutics 127
Characterization of alpha2-delta1 expression and response to chronic treatment with gabapentin in a mouse model of neuropathic pain. 127
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 124
Involvment of metabotropic glutamate receptors in behavioural effects of bergamot essential oil 120
Role of mGlu-5 and mGlu2/3 receptors in behavioural effects of bergamot essential oil 119
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 116
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 116
Pain assessment for better pharmacological treatment of pain and agitation in severe dementia: I-MOBID2 validation. 114
Characterization of mechanical and thermal nociception in ageing mice. 114
Innovazione farmacoterapeutica necessaria nella gestione dei behavioral and psychological symptoms nella demenza. 114
Characterisation of pain sensitivity in ageing mice 113
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 111
Behavioral and psychological symptoms of dementia (BPSD): evidence on pharmacoutilization from a large sample in the real-world setting 110
The need for better access to pain treatment: learning from drug consumption trends in the USA 108
CANNABIS UPDATE 2.0 107
Eptinezumab for the treatment of migraine 104
Need for a clinical trial investigating efficacy and safety of oral spray nabiximols for pain and agitation treatment in severe dementia patients. 102
Pharmacoutilization data-driven AI-assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 101
Gender differences in pain response to peripheral injury in mice. 101
Trattamento dei pazienti affetti da demenza in un real-world setting della regione Calabria: gestione dei sintomi comportamentali e del dolore. 100
Evidenze farmacoepidemiologiche a favore di un ridotto accesso alla cura del dolore in pazienti trattati con inibitori delle colinesterasi e memantina nel territorio dell’Azienda Sanitaria Provinciale di Cosenza. 100
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 98
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 98
Validation of an international pain assessment tool to improve pharmacological treatment of pain and agitation in severe dementia. 98
Current opportunities for drug repurposing in pain management: is there a role for autophagy modulation? 98
Pharmacoepidemiology evidence in favour of a reduced access to pain treatment in patients assuming acetylcholinesterase inhibitors and memantine in the provincial health district of Cosenza . 97
Indagine farmacoepidemiologica sul trattamento antidolorifico dei pazienti affetti da demenza in Calabria. 96
Translation of bergamot essential oil in clinical trial for control of behavioral and psychological symptoms of dementia (BPSD) 95
Neuropsychiatric symptoms of dementia: role of pain and essential oil of bergamot as a novel therapeutic. 94
New trends in pain research: From basic research to clinical translation 91
Real-world evidence supports combination therapy with anti-CGRP mAbs and onabotulinumtoxinA for chronic migraine 89
Basi razionali per la traslazione clinica dell’olio essenziale di bergamotto. 85
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-like Behaviour in Female Rats 82
Influence of aging on nociception in C57BL/6 mice. 77
Gas Chromatography–Mass Spectroscopy ( GC – MS ) Simultaneous Determination of Limonene, Linalool, and Linalyl Acetate in Rat Plasma Following Transdermal Administration of the Essential Oil of Bergamot Loaded Onto Solid Lipid Nanoparticles ( NanoBEO ) 76
Evidence from the real-world of limited access to pain treatment in a large sample of patients suffering from dementia. 73
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 72
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 70
Neuropharmacology of behavioral disorders in dementia. 65
R&D of an essential oil in dementia: the case model of Bergamot 61
Dolore. 49
Targeting pain to control neuropsychiatric symptoms of dementia: the need for tailored clinical trials. 46
Modulating the microbiota-gut-brain axis via bergamot essential oil: a multi-target approach to mitigate systemic triggers of neuroinflammation 44
Neuropharmacology of the neuropsychiatric symptoms of dementia: possible targets for novel therapeutic approaches 32
NANOTECHNOLOGY-BASED DELIVERY SYSTEM OF BERGAMOT ESSENTIAL OIL, METHOD OF PREPARATION OF THE SYSTEM AND USES THEREOF 28
Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy 24
Hericenone C exhibits anti-nociceptive effects through RORα-mediated suppression of TLR4 transcription 24
Totale 6.973
Categoria #
all - tutte 38.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022436 0 0 0 4 34 30 61 89 19 26 54 119
2022/2023665 68 76 35 88 52 63 21 105 65 20 46 26
2023/2024587 45 31 33 25 33 114 23 27 64 29 37 126
2024/2025946 67 130 40 55 67 85 39 46 147 31 94 145
2025/20262.994 299 183 208 252 603 258 299 171 244 268 83 126
2026/2027786 168 64 179 375 0 0 0 0 0 0 0 0
Totale 6.973